Market revenue in 2023 | USD 12,339.6 million |
Market revenue in 2030 | USD 17,573.9 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Pre-Clinical |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Key market players worldwide | Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, GVK Biosciences, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, PAREXEL, Dassault Systemes SE, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, SGS AG, Worldwide Clinical Trials, Wuxi AppTec Co Ltd, Caidya |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract research organization market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 75.79% in 2023. Horizon Databook has segmented the North America healthcare contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Growth in the region can be attributed to the increasing number of clinical trials, high R&D spending, and outsourcing of trials. In addition, the growing biosimilars & biologics industry and the globalization of clinical trials are expected to drive the healthcare CRO market growth during the forecast period.
The rise of biologics and related biosimilars has been a major factor in the mergers & acquisitions of Contract Development & Manufacturing Organizations (CDMOs) and CROs.
Developing biologic and biosimilar drugs requires significantly more time & money than developing small molecules and generic drugs. Hence, smaller pharmaceutical clients have mainly outsourced to partners.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America healthcare contract research organization market , including forecasts for subscribers. This continent databook contains high-level insights into North America healthcare contract research organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account